These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2600498)

  • 1. [Recent trend in the research of hyperlipidemia in Japan (3). Apolipoprotein E polymorphism and hyperlipoproteinemia].
    Yamamura T
    Nihon Naika Gakkai Zasshi; 1989 Oct; 78(10):1410-3. PubMed ID: 2600498
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apolipoprotein E polymorphism, hyperlipidemia and risk of myocardial infarct].
    Assmann G; Lenzen HJ
    Internist (Berl); 1985 Nov; 26(11):692-700. PubMed ID: 3908375
    [No Abstract]   [Full Text] [Related]  

  • 3. Apolipoprotein E alleles and hyperlipoproteinemia in Japan.
    Eto M; Watanabe K; Ishii K
    Clin Genet; 1988 Oct; 34(4):246-51. PubMed ID: 3233777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
    Kobori S; Nakamura N; Uzawa H; Shichiri M
    Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype study of apolipoprotein E isoforms in hyperlipoproteinaemic patients.
    Ghiselli G; Gregg RE; Zech LA; Schaefer EJ; Brewer HB
    Lancet; 1982 Aug; 2(8295):405-7. PubMed ID: 6124804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E polymorphism in northwestern Greece: frequency and effect on lipid parameters.
    Liberopoulos E; Miltiadous G; Hatzivassiliou M; Ayrton N; Bairaktari E; Cariolou M; Elisaf M
    Ann Clin Lab Sci; 2004; 34(3):347-54. PubMed ID: 15487712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E mutants, hyperlipidemia and arteriosclerosis.
    Utermann G
    Adv Exp Med Biol; 1985; 183():173-88. PubMed ID: 4036699
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of apolipoprotein E7 (apolipoprotein E-Suita) gene from a patient with hyperlipoproteinemia.
    Tajima S; Yamamura T; Menju M; Yamamoto A
    J Biochem; 1989 Feb; 105(2):249-53. PubMed ID: 2470732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apolipoprotein E genetic polymorphism].
    Kokubo Y; Tanaka H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():799-805. PubMed ID: 11347177
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of apolipoprotein E5 gene from a patient with hyperlipoproteinemia.
    Tajima S; Yamamura T; Yamamoto A
    J Biochem; 1988 Jul; 104(1):48-52. PubMed ID: 2851587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene mutations in familial hyperlipidemias].
    Yamamoto A
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():661-9. PubMed ID: 11351667
    [No Abstract]   [Full Text] [Related]  

  • 12. Frequencies of apolipoproteins E5 and E7 in apparently healthy Japanese.
    Tsuchiya S; Yamanouchi Y; Onuki M; Yamakawa K; Miyazaki R; Taya T; Kondo I; Ohnuki M; Hamaguchi H
    Jinrui Idengaku Zasshi; 1985 Dec; 30(4):271-8. PubMed ID: 3836312
    [No Abstract]   [Full Text] [Related]  

  • 13. [Phenotype of apolipoprotein E, hyperlipidemia and atherosclerosis].
    Davignon J; Roederer G
    Union Med Can; 1988 Feb; 117(1):56-61. PubMed ID: 3376345
    [No Abstract]   [Full Text] [Related]  

  • 14. [Apolipoproteinopathies].
    Assmann G
    Klin Wochenschr; 1983 Feb; 61(4):169-82. PubMed ID: 6405080
    [No Abstract]   [Full Text] [Related]  

  • 15. Apolipoprotein E polymorphism, serum lipids and occurrence of "double pre-betalipoproteinemia' (DPBL) in subjects from two different populations.
    Pagnan A; Zanetti G; Bonanome A; Biffanti S; Ehnholm C; Keso L; Lukka M
    Atherosclerosis; 1987 May; 65(1-2):23-8. PubMed ID: 3496894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of apolipoprotein E polymorphism in normal healthy controls from northern India.
    Chhabra S; Agarwal DP; Vasisht S; Luthra K; Narang R; Manchanda SC; Srivastava LM; Das N
    Dis Markers; 2000; 16(3-4):159-61. PubMed ID: 11381199
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
    Petrovic D; Zorc M; Peterlin B
    Folia Biol (Praha); 2000; 46(5):181-5. PubMed ID: 11055796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic determinants of dyslipidemias.
    Breslow JL
    Monogr Atheroscler; 1985; 13():25-31. PubMed ID: 3937050
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased Frequency of Apo E-ND phenotype and hyperapobeta-lipoproteinemia in normolipidemic subjects with xanthelasmas of the eyelids.
    Douste-Blazy P; Marcel YL; Cohen L; Giroux JM; Davignon J
    Ann Intern Med; 1982 Feb; 96(2):164-9. PubMed ID: 7059063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.